News – Page 1134 – Endpoints News

As crisis deepens, Teva's board sees off CEO Erez Vigodman and an activist urges a split into two companies

9 years ago

Cellectis preps for groundbreaking US trials for an off-the-shelf CAR-T therapy

9 years ago

Chondrial bags a $22M A round for mitochondrial R&D; Ariad filed marketing app for brigatinib

9 years ago

Malin backs another microbiome upstart as Artizan breaks out of ‘covert’ role

9 years ago

With Trump’s new FDA commish nominee looming, industry execs are keeping their fingers crossed for Scott Gottlieb

9 years ago

LabCorp pursuing an $8B PPD buyout, tie up with Covance — report

9 years ago

Bristol-Myers partner Innate concedes a PhII flop for I/O drug lirilumab in fighting AML

9 years ago

After promising Trump new US jobs, Eli Lilly sets out to chop 200 R&D staffers

9 years ago

Stemline comes clean on patient death, but questions linger; Life sciences fund launches with €100M

9 years ago

Vowing to help, Trump manages to spark an angry protest against policies and a plan to revamp the FDA

9 years ago

Biotech dealmaker Ramaswamy raises another $55M for Axovant

9 years ago

Amgen rips off its $10B M&A cap, looking for deals “large and small”

9 years ago

Amgen scores positive PhIII cardio outcomes for its PCSK9 franchise drug Repatha

9 years ago

J&J makes new investments in microbiome R&D; UK’s Arix out to raise £100 million for new biotech investments

9 years ago

AstraZeneca chief is betting the company’s future on a single roll of the dice

9 years ago

Dear President Trump: Don’t destroy the FDA we know and respect

9 years ago

Versant backs a rebooted Tarveda with $30M round for pipeline development

9 years ago

Cytokinetics chief Blum grabs $100M royalty deal to fund an expanded marketing plan for PhIII heart drug

9 years ago

Celgene vet Daniel takes a startup role at Vividion, with $50M in hand for platform construction

9 years ago

Aviragen shares plunge as RSV antiviral flunks a small PhIIa study

9 years ago

Canada hands Sanofi, Regeneron their first OK for sarilumab; Rigel raises $40 million

9 years ago

Struggling Ophthotech organizes a global hunt for some new opthalmology deals

9 years ago

Big Pharma promised Trump new American jobs for tax cuts and deregulation. But the vow comes after a 5-year purge

9 years ago

Catabasis shares are shredded after lead drug flops in PhII Duchenne MD study

9 years ago

First page Previous page 1131 1132 113311341135 1136 1137 Next page Last page